SEARCH

SEARCH BY CITATION

References

  • Blondon, M., Wiggins, K.L., McKnight, B., Psaty, B.M., Rice, K.M., Heckbert, S.R. & Smith, N.L. (2013) The association of smoking with venous thrombosis in women. A population-based, case–control study. Thrombosis and haemostasis, 109, 891896.
  • Brækkan, S.K., Hald, E.M., Mathiesen, E.B., Njølstad, I., Wilsgaard, T., Rosendaal, F.R. & Hansen, J.-B. (2012) Competing risk of atherosclerotic risk factors for arterial and venous thrombosis in a general population: the tromso study. Arteriosclerosis, thrombosis, and vascular biology, 32, 487491.
  • Curb, J.D., Prentice, R.L., Bray, P.F., Langer, R.D., Van Horn, L., Barnabei, V.M., Bloch, M.J., Cyr, M.G., Gass, M., Lepine, L., Rodabough, R.J., Sidney, S., Uwaifo, G.I. & Rosendaal, F.R. (2006) Venous thrombosis and conjugated equine estrogen in women without a uterus. Archives of internal medicine, 166, 772780.
  • Cushman, M., Kuller, L.H., Prentice, R., Rodabough, R.J., Psaty, B.M., Stafford, R.S., Sidney, S., Rosendaal, F.R. & Women's Health Initiative Investigators (2004) Estrogen plus progestin and risk of venous thrombosis. JAMA: The Journal of the American Medical Association, 292, 15731580.
  • Pomp, E.R., Rosendaal, F.R. & Doggen, C.J.M. (2008) Smoking increases the risk of venous thrombosis and acts synergistically with oral contraceptive use. American journal of hematology, 83, 97102.
  • Rossouw, J.E., Anderson, G.L., Prentice, R.L., LaCroix, A.Z., Kooperberg, C., Stefanick, M.L., Jackson, R.D., Beresford, S.A.A., Howard, B.V., Johnson, K.C., Kotchen, J.M., Ockene, J. & Writing Group for the Women's Health Initiative Investigators (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA: The Journal of the American Medical Association, 288, 321333.
  • Rossouw, J.E., Prentice, R.L., Manson, J.E., Wu, L., Barad, D., Barnabei, V.M., Ko, M., LaCroix, A.Z., Margolis, K.L. & Stefanick, M.L. (2007) Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA: The Journal of the American Medical Association, 297, 14651477.
  • Schafer, J.L. (1999) Multiple imputation: a primer. Statistical methods in medical research, 8, 315.
  • Smith, N.L., Heckbert, S.R., Lemaitre, R.N., Reiner, A.P., Lumley, T., Weiss, N.S., Larson, E.B., Rosendaal, F.R. & Psaty, B.M. (2004) Esterified estrogens and conjugated equine estrogens and the risk of venous thrombosis. JAMA: The Journal of the American Medical Association, 292, 15811587.
  • Sweetland, S., Beral, V., Balkwill, A., Liu, B., Benson, V.S., Canonico, M., Green, J., Reeves, G.K. & The Million Women Study Collaborators (2012) Venous thromboembolism risk in relation to use of different types of postmenopausal hormone therapy in a large prospective study. Journal of Thrombosis and Haemostasis: JTH, 10, 22772286.